If you wear glasses, you remember the moment. You put those brand-new lenses in front of your eyes, and suddenly you saw every swirl of your fingerprint, every vein of a leaf from 10 paces away. Precision cancer medicine works much the same way. It&rsquo;s the way the world&rsquo;s leading cancer experts get a crystal-clear picture of precisely what drives a particular cancer&rsquo;s growth. By studying cancer cells at the molecular level (genomics), the OSUCCC &ndash; James experts get a much crisper vision of what&rsquo;s fueling those particular cells to grow and spread. This, in turn, enables them to create a treatment plan with highly targeted therapies tailored specifically for that patient&rsquo;s cancer. &ldquo;There is no routine cancer,&rdquo; says Sameek Roychowdhury, MD, PhD, genomics expert and medical oncologist at the OSUCCC &ndash; James. &ldquo;Because no two cancers are the same, we need to get to the root of why one person&rsquo;s lung cancer, for example, responds well to a particular drug, but another person&rsquo;s lung cancer refuses to cooperate with that same therapy. &ldquo;With genomic sequencing technology and precision cancer care,&rdquo; Roychowdhury continues, &ldquo;we identify exactly what genes have changed. We can see a tumor&rsquo;s make-up, telling us which treatments may work best and which ones won&rsquo;t, and we&rsquo;re always developing new drugs to treat specific mutations.&rdquo; At the OSUCCC &ndash; James, teams of experts review a patient&rsquo;s tumor data and interpret it in the context of novel &ldquo;smart drugs&rdquo; in clinical trials available at the OSUCCC &ndash; James. &ldquo;Based on an individual patient&rsquo;s genomic tumor data, we have a chance to choose drugs that are more likely to work,&rdquo; Roychowdhury says. And for patients, that means the potential for more targeted options, fewer side effects and better outcomes.